Blog Post

Centice Drug Analysis Systems Sold to Major Federal Agency to Aid in Prescription Pill Abuse Operations

Nationwide program allows agents to identify over 3,800 prescription pills and illicit drugs

 

RESEARCH TRIANGLE PARK, N.C. (October 28, 2014) – Centice Corporation, a pioneer in narcotic and pharmaceutical identification using Raman spectroscopy technology, today announced that a major federal agency is now using the Centice MFL-3000 drug analysis system to aid in prescription pill abuse operations. The operations focus on stopping the illegal use of prescription drugs for recreational purposes, doctor shopping, and pill mills, across the United States.

 

Prescription drug abuse continues to be the nation’s fastest growing drug problem. The abuse of controlled prescription drugs (CPDs) poses a significant drug threat to the United States and places a considerable burden on law enforcement and public health resources. Nationally, 28.1 percent of law enforcement agencies responding to the 2013 National Drug Threat Survey (NDTS) reported CPDs as the greatest drug threat, up from 9.8 percent in 2009.

 

“Centice’s MFL-3000 drug analysis system has become law enforcement’s “go to” tool for the rapid, non-destructive detection of pharmaceutical and narcotic substances,” said John Goehrke, CEO of Centice. “The system quickly and accurately identifies illicit narcotics, cutting agents street mixtures, precursors, and controlled prescription drugs.”

 

Centice is a leader in delivering unique technology and systems for the identification of narcotic and pharmaceutical substances. Based on proven Raman spectroscopy technology, Centice’s portable system identifies pills (including scraped / unmarked / crushed), or unknown illicit substances in just seconds, without destroying evidence. With a library of over 3,800 narcotics, precursors, synthetic drugs, and prescription pills, the Centice Drug Analysis System can identify the vast majority of illicit substances found on the street. In addition, the identification of the strength of cutting agents and precursors helps give valuable real time intelligence to narcotic investigations. Centice software handles both direct library matches and compound mixtures, in which substances of interest are mixed with cutting agents and their identification can be important tools for law enforcement, helping investigators identify a specific dealer or lead to a larger arrest.

 

Operating worldwide through a network of distributors and support organizations, Centice sells to numerous markets including international governments, federal agencies, prisons, drug task forces, as well as local law enforcement agencies. Currently, systems are deployed across five continents and in 45 US states and territories.

 

About Centice
Centice Corporation is a leader in delivering unique technology and systems for the identification of narcotic and pharmaceutical substances. The product line is based on Centice’s patented coded aperture Raman spectroscopy technology, allowing law enforcement agencies to quickly identify over 3,800 Controlled Prescription Drugs, illicit narcotics and cutting agent mixtures, providing law enforcement with technology typically only available to crime labs. Operating worldwide through a network of distributors and support organizations the company sells to numerous markets including international governments, federal agencies, prisons, drug task forces, as well as local law enforcement agencies. The company is headquartered in Morrisville, NC was founded in 2004 from technology created at Duke University.